The in vitro action of FK 565, bleomycin and cyclosporin A on different cell populations, with respect to the release of GM-CSF in the mouse.
The experimental immunostimulatory tripeptide FK 565, the anti-tumor antibiotic Bleomycin and the immunosuppressive agent Cyclosporin A were examined for their in vitro effects on granulocyte-macrophage colony stimulating factor (GM-CSF) production utilizing different cell populations from three distinct murine stains. FK 565 produced an increase in GM-CSF release in all three experimental models used, providing evidence that FK 565 is among other things, a macrophage stimulating agent. Bleomycin increased GM-CSF release in the BALB/c and the 'Scid' mouse. Paradoxically with cells from the 'nude' mouse a significant decrease was observed, indicating that Bleomycin may induce a suppressive effect on B-cells. Cyclosporin A was found to inhibit the release of GM-CSF from BALB/c mice, however, no effect was observed in either 'nude' or 'Scid' mice.